title: Measuring movement disorders in antipsychotic drug trials: the need to define a new standard.
authors.forename: Anton J M
authors.initials: AJ
authors.lastname: Loonen
authors.forename: Herman M
authors.initials: HM
authors.lastname: van Praag
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000266:history; D018849:Controlled Clinical Trials as Topic; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D023381:Endpoint Determination; D049673:History, 20th Century; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy; D009460:Neurologic Examination / Q000379:methods* / Q000592:standards; D012016:Reference Values
chemical_list: D014150:Antipsychotic Agents